|4Jul 5, 5:32 PM ET

DOUGLAS RICHARD 4

4 · Aldeyra Therapeutics, Inc. · Filed Jul 5, 2023

Insider Transaction Report

Form 4
Period: 2023-06-30
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-30+21,22221,222 total
    Exercise: $8.39Exp: 2033-06-29Common Stock (21,222 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-30+5,4885,488 total
    Exercise: $8.39Exp: 2033-06-29Common Stock (5,488 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-06-30+640640 total
    Exercise: $8.39Exp: 2033-06-29Common Stock (640 underlying)
Footnotes (3)
  • [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
  • [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
  • [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4